Logo image of MNTK

MONTAUK RENEWABLES INC (MNTK) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MNTK - US61218C1036 - Common Stock

1.78 USD
+0.05 (+2.89%)
Last: 12/4/2025, 1:16:39 PM
Fundamental Rating

2

Overall MNTK gets a fundamental rating of 2 out of 10. We evaluated MNTK against 20 industry peers in the Independent Power and Renewable Electricity Producers industry. Both the profitability and financial health of MNTK have multiple concerns. While showing a medium growth rate, MNTK is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

MNTK had negative earnings in the past year.
MNTK had a positive operating cash flow in the past year.
Of the past 5 years MNTK 4 years were profitable.
Each year in the past 5 years MNTK had a positive operating cash flow.
MNTK Yearly Net Income VS EBIT VS OCF VS FCFMNTK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

1.2 Ratios

MNTK's Return On Assets of -2.40% is on the low side compared to the rest of the industry. MNTK is outperformed by 70.00% of its industry peers.
The Return On Equity of MNTK (-3.53%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.4%
ROE -3.53%
ROIC N/A
ROA(3y)5.88%
ROA(5y)3.58%
ROE(3y)8.42%
ROE(5y)5.13%
ROIC(3y)N/A
ROIC(5y)N/A
MNTK Yearly ROA, ROE, ROICMNTK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

In the last couple of years the Profit Margin of MNTK has remained more or less at the same level.
MNTK's Operating Margin has declined in the last couple of years.
MNTK has a worse Gross Margin (34.69%) than 60.00% of its industry peers.
In the last couple of years the Gross Margin of MNTK has remained more or less at the same level.
MNTK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.69%
OM growth 3Y45.12%
OM growth 5Y-4.7%
PM growth 3YN/A
PM growth 5Y0.19%
GM growth 3Y-2.25%
GM growth 5Y-0.15%
MNTK Yearly Profit, Operating, Gross MarginsMNTK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

2

2. Health

2.1 Basic Checks

MNTK does not have a ROIC to compare to the WACC, probably because it is not profitable.
MNTK has more shares outstanding than it did 1 year ago.
MNTK has more shares outstanding than it did 5 years ago.
MNTK has a better debt/assets ratio than last year.
MNTK Yearly Shares OutstandingMNTK Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M
MNTK Yearly Total Debt VS Total AssetsMNTK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of 1.68, we must say that MNTK is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.68, MNTK is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
MNTK has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
MNTK has a Debt to Equity ratio of 0.21. This is in the better half of the industry: MNTK outperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 1.68
ROIC/WACCN/A
WACC8.16%
MNTK Yearly LT Debt VS Equity VS FCFMNTK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

MNTK has a Current Ratio of 0.33. This is a bad value and indicates that MNTK is not financially healthy enough and could expect problems in meeting its short term obligations.
MNTK's Current ratio of 0.33 is on the low side compared to the rest of the industry. MNTK is outperformed by 90.00% of its industry peers.
A Quick Ratio of 0.33 indicates that MNTK may have some problems paying its short term obligations.
MNTK's Quick ratio of 0.33 is on the low side compared to the rest of the industry. MNTK is outperformed by 85.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.33
MNTK Yearly Current Assets VS Current LiabilitesMNTK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

MNTK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -140.00%.
Measured over the past years, MNTK shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.33% on average per year.
MNTK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.54%.
The Revenue has been growing by 10.70% on average over the past years. This is quite good.
EPS 1Y (TTM)-140%
EPS 3YN/A
EPS 5Y11.33%
EPS Q2Q%-66.67%
Revenue 1Y (TTM)-17.54%
Revenue growth 3Y5.87%
Revenue growth 5Y10.7%
Sales Q2Q%-31.34%

3.2 Future

The Earnings Per Share is expected to grow by 6.34% on average over the next years.
The Revenue is expected to grow by 8.95% on average over the next years. This is quite good.
EPS Next Y-138.25%
EPS Next 2Y-15%
EPS Next 3Y26.83%
EPS Next 5Y6.34%
Revenue Next Year-13.26%
Revenue Next 2Y1.75%
Revenue Next 3Y8.95%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
MNTK Yearly Revenue VS EstimatesMNTK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
MNTK Yearly EPS VS EstimatesMNTK Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.1 0.2 0.3

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MNTK. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 41.06 indicates a quite expensive valuation of MNTK.
Based on the Price/Forward Earnings ratio, MNTK is valued a bit cheaper than 65.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.20, MNTK is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 41.06
MNTK Price Earnings VS Forward Price EarningsMNTK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600

4.2 Price Multiples

65.00% of the companies in the same industry are more expensive than MNTK, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.18
MNTK Per share dataMNTK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as MNTK's earnings are expected to grow with 26.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15%
EPS Next 3Y26.83%

0

5. Dividend

5.1 Amount

MNTK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MONTAUK RENEWABLES INC

NASDAQ:MNTK (12/4/2025, 1:16:39 PM)

1.78

+0.05 (+2.89%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)03-10 2026-03-10/amc
Inst Owners16.67%
Inst Owner Change-0.49%
Ins Owners54.07%
Ins Owner Change0%
Market Cap254.82M
Revenue(TTM)160.68M
Net Income(TTM)-9.20M
Analysts48
Price Target3.23 (81.46%)
Short Float %2.59%
Short Ratio6.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-116.81%
Min EPS beat(2)-413.72%
Max EPS beat(2)180.11%
EPS beat(4)1
Avg EPS beat(4)-139.36%
Min EPS beat(4)-413.72%
Max EPS beat(4)180.11%
EPS beat(8)3
Avg EPS beat(8)-76.06%
EPS beat(12)3
Avg EPS beat(12)-77.59%
EPS beat(16)3
Avg EPS beat(16)-69.3%
Revenue beat(2)1
Avg Revenue beat(2)0.46%
Min Revenue beat(2)-0.71%
Max Revenue beat(2)1.62%
Revenue beat(4)1
Avg Revenue beat(4)-13.09%
Min Revenue beat(4)-51.79%
Max Revenue beat(4)1.62%
Revenue beat(8)2
Avg Revenue beat(8)-11.35%
Revenue beat(12)3
Avg Revenue beat(12)-12.63%
Revenue beat(16)5
Avg Revenue beat(16)-7.61%
PT rev (1m)0%
PT rev (3m)11.72%
EPS NQ rev (1m)-8.33%
EPS NQ rev (3m)65.04%
EPS NY rev (1m)0%
EPS NY rev (3m)-34.97%
Revenue NQ rev (1m)-0.82%
Revenue NQ rev (3m)-4.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.82%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 41.06
P/S 1.59
P/FCF N/A
P/OCF 8.29
P/B 0.98
P/tB 1.06
EV/EBITDA 13.18
EPS(TTM)-0.06
EYN/A
EPS(NY)0.04
Fwd EY2.44%
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)0.21
OCFY12.06%
SpS1.12
BVpS1.82
TBVpS1.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.4%
ROE -3.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.69%
FCFM N/A
ROA(3y)5.88%
ROA(5y)3.58%
ROE(3y)8.42%
ROE(5y)5.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.89%
ROCE(5y)6.65%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y45.12%
OM growth 5Y-4.7%
PM growth 3YN/A
PM growth 5Y0.19%
GM growth 3Y-2.25%
GM growth 5Y-0.15%
F-Score3
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 2.35
Cap/Depr 302.02%
Cap/Sales 52.34%
Interest Coverage N/A
Cash Conversion 131.56%
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.33
Altman-Z 1.68
F-Score3
WACC8.16%
ROIC/WACCN/A
Cap/Depr(3y)223.62%
Cap/Depr(5y)158.87%
Cap/Sales(3y)27.46%
Cap/Sales(5y)21.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-140%
EPS 3YN/A
EPS 5Y11.33%
EPS Q2Q%-66.67%
EPS Next Y-138.25%
EPS Next 2Y-15%
EPS Next 3Y26.83%
EPS Next 5Y6.34%
Revenue 1Y (TTM)-17.54%
Revenue growth 3Y5.87%
Revenue growth 5Y10.7%
Sales Q2Q%-31.34%
Revenue Next Year-13.26%
Revenue Next 2Y1.75%
Revenue Next 3Y8.95%
Revenue Next 5YN/A
EBIT growth 1Y-112.86%
EBIT growth 3Y53.64%
EBIT growth 5Y5.49%
EBIT Next Year-7.01%
EBIT Next 3Y17.51%
EBIT Next 5Y5.16%
FCF growth 1Y-278.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.8%
OCF growth 3Y0.71%
OCF growth 5Y9.49%

MONTAUK RENEWABLES INC / MNTK FAQ

What is the ChartMill fundamental rating of MONTAUK RENEWABLES INC (MNTK) stock?

ChartMill assigns a fundamental rating of 2 / 10 to MNTK.


What is the valuation status for MNTK stock?

ChartMill assigns a valuation rating of 2 / 10 to MONTAUK RENEWABLES INC (MNTK). This can be considered as Overvalued.


How profitable is MONTAUK RENEWABLES INC (MNTK) stock?

MONTAUK RENEWABLES INC (MNTK) has a profitability rating of 2 / 10.


What is the earnings growth outlook for MONTAUK RENEWABLES INC?

The Earnings per Share (EPS) of MONTAUK RENEWABLES INC (MNTK) is expected to decline by -138.25% in the next year.